CBD (Cannabidiol) is one of 100+ compounds found in cannabis that belong to a class of molecules called phytocannabinoids. Of these compounds, CBD and THC (tetrahydrocannabinol) are usually present in the highest concentrations, and are therefore the most recognized and studied. We believe in synergic effect of all cannabinoids, terpenes and flavonoids found naturally in the plants genetics and the entourage effect of the plant to be the most effective for most clients.
“Cannabis is inherently polypharmaceutical,” Dr. John McPartland notes, “and synergy arises from interactions between its multiple components.”
CBD does not cause a high, unlike THC. The reason why CBD is non-psychoactive is due to its lack of affinity for CB1 receptors. CB1 receptors are found in high concentrations in the brain, and are the pathways responsible for the psychoactive effects of THC.
Around 200 terpenes have been found in cannabis. The terpenes in Cannabis have given the plant an enduring, evolutionary advantage.
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo, Francesca Borrelli, Raffaele Capasso, Vincenzo Di Marzo and Raphael Mechoulam http://www.ncbi.nlm.nih.gov/pubmed/19729208
Org. Biomol. Chem., 2005, 3, 1116 – 1123
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors
Lumír O. Hanus, Susanna Tchilibon, Datta E. Ponde, Aviva Breuer,
Ester Fride and Raphael Mechoulam http://www.ncbi.nlm.nih.gov/pubmed/15750656
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Antonio Waldo Zuardi
Department of Neurology, Psychiatry and Medical Psychology,
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo (USP), Brazil http://bit.ly/a3lcSS